Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.380
0.00 (0.00%)
At close: May 13, 2026, 4:00 PM EDT
1.460
+0.080 (5.80%)
After-hours: May 13, 2026, 7:49 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $1.97 million as of May 13, 2026. Its market cap has decreased by -56.33% in one year.
Market Cap
1.97M
Enterprise Value
-2.61M
1-Year Change
-56.33%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $1.97M, a decrease of -92.52%. That is a compound annual growth rate of -28.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 1.97M | -66.39% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensysce Biosciences | 2.67M |
| Decoy Therapeutics | 2.56M |
| Oragenics | 2.47M |
| Biodexa Pharmaceuticals | 2.41M |
| HCW Biologics | 2.35M |
| Bone Biologics | 2.33M |
| AIM ImmunoTech | 2.21M |
| Artelo Biosciences | 2.17M |